# EDGAR Filing Document

**Accession Number:** 0001626878
**File Stem:** 0001104659-23-003282
**Filing Date:** 2023-1
**Character Count:** 7854
**Document Hash:** 5e035bfeea0d64245374947bc3ec1d0f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-003282.hdr.sgml**: 20230112

**ACCESSION NUMBER**: 0001104659-23-003282

**CONFORMED SUBMISSION TYPE**: SC 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230112

**DATE AS OF CHANGE**: 20230112

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** XBiotech Inc.
- **CENTRAL INDEX KEY:** 0001626878
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88810
- **FILM NUMBER:** 23525181

**BUSINESS ADDRESS:**
- **STREET 1:** 5217 WINNEBAGO LANE
- **STREET 2:** BUILDING 4, SUITE 100
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744
- **BUSINESS PHONE:** 512-386-2900

**MAIL ADDRESS:**
- **STREET 1:** 5217 WINNEBAGO LANE
- **STREET 2:** BUILDING 4, SUITE 100
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lombard International Assurance S.A.
- **CENTRAL INDEX KEY:** 0001767788
- **IRS NUMBER:** 981273128
- **STATE OF INCORPORATION:** N4
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 4, RUE LOU HEMMER
- **CITY:** FINDEL
- **STATE:** N4
- **ZIP:** 1748
- **BUSINESS PHONE:** 00352346191502

**MAIL ADDRESS:**
- **STREET 1:** 4, RUE LOU HEMMER
- **CITY:** FINDEL
- **STATE:** N4
- **ZIP:** 1748

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 13G**

**Under the Securities Exchange Act of 1934**

**XBiotech Inc.**

**(Name of Issuer)**

**Common stock, no par value per share**

**(Title of Class of Securities)**

**98400H102**

**(CUSIP Number)**

**19 May 2022**

**(Date of Event Which Requires Filing of this Statement)**

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

⌧ Rule 13d-1(b)

◻ Rule 13d-1(c)

◻ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 98400H102

---

| | |
|:---|:---|
| 1 | Name of Reporting Person:<br>Lombard International Assurance S.A. <br>|
| 2 | Check the Appropriate Box if a Member of a Group (see instructions)<br> (a) ◻ (b) ⌧<br>|
| 3 | SEC Use Only<br>|
| 4 | Citizenship or Place of Organization<br>Luxembourg  |

---

---

| | | |
|:---|:---|:---|
| Number <br> of <br> Shares <br> Beneficially <br> Owned <br> by <br> Each <br> Reporting <br> Person <br> With : | 5 | Sole Voting Power<br>1,114,256  |
| Number <br> of <br> Shares <br> Beneficially <br> Owned <br> by <br> Each <br> Reporting <br> Person <br> With : | 6 | Shared Voting Power<br>None  |
| Number <br> of <br> Shares <br> Beneficially <br> Owned <br> by <br> Each <br> Reporting <br> Person <br> With : | 7 | Sole Dispositive Power<br>1,114,256  |
| Number <br> of <br> Shares <br> Beneficially <br> Owned <br> by <br> Each <br> Reporting <br> Person <br> With : | 8 | Shared Dispositive Power<br>None  |

---

---

| | |
|:---|:---|
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1,114,256  |
| 10<br>| Check if the Aggregate Amount in Row (9) Excludes Certain Shares ◻ |
| 11<br>| Percent of Class Represented by Amount in Row (9)<br>3.66%  |
| 12<br>| Type of Reporting Person<br>FI  |

---

---

| | |
|:---|:---|
| **Item 1(a).** | Name of Issuer. |

---

XBiotech Inc. (the "Issuer").

---

| | |
|:---|:---|
| **Item 1(b).** | Address of Issuer's Principal Executive Offices. |

---

8201 E. Riverside Dr Bldg. 4, Ste. 100

Austin, TX 78744

---

| | |
|:---|:---|
| **Item 2(a).** | Names of Persons Filing. |

---

This Schedule 13G is filed on behalf of Lombard International Assurance S.A.

---

| | |
|:---|:---|
| **Item 2(b).** | Address or Principal Business Office or, if none, Residence. |

---

Lombard International Assurance S.A.

4, rue Lou Hemmer

L-1748 Luxembourg

Luxembourg

---

| | |
|:---|:---|
| **Item 2(c).** | Citizenship. |

---

Luxembourg

---

| | |
|:---|:---|
| **Item 2(d).** | Title of Class of Securities. |

---

Common Stock

---

| | |
|:---|:---|
| **Item 2(e).** | CUSIP Number. |

---

98400H102

**Item 3.** If this statement is filed pursuant to Rule 13d-1(b), or 13d-3(b) or (c), check whether the person filing is a:

---

| | | |
|:---|:---|:---|
|  | ◻ | Not Applicable |
| (a) | ◻ | Broker or dealer registered under section 15 of the Act; |
| (b) | ◻ | Bank as defined in section 3(a)(6) of the Act; |
| (c) | ◻ | Insurance company as defined in section 3(a)(19) of the Act; |
| (d) | ◻ | Investment company registered under section 8 of the Investment Company Act of 1940; |
| (e) | ◻ | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); |
| (f) | ◻ | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); |
| (g) | ◻ | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); |
| (h) | ¨ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; |
| (i) | ◻ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; |
| (j) | ⌧ | A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); |
| (k) | ◻ | Group, in accordance with Rule 13d-1(b)(1)(ii)(K). |

---

**Item 4.** **Ownership:**

**(a) Amount beneficially owned:**

1,114,256 shares

**(b) Percent of class:**

3.66%

------

**(c) Number of shares as to which the person has:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(i) Sole power to vote or to direct the vote**

1,114,256

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(ii) Shared power to vote or to direct the vote**

None

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(iii) Sole power to dispose or to direct the vote**

1,114,256

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(iv) Shared power to dispose or to direct the disposition of**

None

**Item 5.** **Ownership of Five Percent or Less of a Class.**

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ⌧

**Item 6.** **Ownership of More than Five Percent on Behalf of Another Person.**

Not applicable.

**Item 7.** **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.**

Not applicable.

**Item 8.** **Identification and Classification of Members of the Group.**

Not applicable

**Item 9.** **Notice of Dissolution of Group.**

Not applicable.

**Item 10.** **Certifications.**

Not applicable.

**SIGNATURE**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | | |
|:---|:---|:---|
| Dated: 11 January 2023 | Lombard International Assurance S.A. | Lombard International Assurance S.A. |
|  |  | /s/ Thierry Leung |
|  |  | Thierry Leung – Head of Fund Administration |
|  |  | /s/ Thibaut Velghe |
|  |  | Thibaut Velghe – Head of Asset Oversight |

---